Operator of a biopharmaceutical company intended to cure patients by designing and developing a pipeline of therapeutics for various treatments. The company uses artificial intelligence-powered technology and designs single and multi-specific antibodies precisely targeting predefined epitopes to execute novel biological programs focusing on oncology and autoimmune diseases, enabling patients to meaningfully improve their lives.
Location: United States, Massachusetts, Boston
Investors 2
| Date | Name | Website |
| - | Western Te... | westerntec... |
| 20.01.2022 | aMoon Fund | amoon.fund... |
Mentions in press and media 3
| Date | Title | Description |
| 20.11.2022 | Онкологические больные тестируют первые в мире «умные качества новых антител», сделанные в Израиле | 20 ноября 2022г. По словам изобретателя, разработанные компьютером антитела можно запрограммировать так, чтобы они делали гораздо больше, если они были созданы с нуля, чем когда они основаны на антителах животных/человека. 0 Обсудить 6 прос... |
| 08.01.2021 | ATP and Biolojic Design Launch Aulos Bioscience to Develop Highly Differentiated IL-2 Antibody Approach to Fighting Cancer | Immuno-oncology spinout from Biolojic Design created with $40M Series A financing from ATP |
| 08.01.2021 | ATP and Biolojic Design Launch Aulos Bioscience to Develop Highly Differentiated IL-2 Antibody Approach to Fighting Cancer | Immuno-oncology spinout from Biolojic Design created with $40M Series A financing from ATP Aulos Bioscience to Present at the 39th Annual J.P. Morgan Healthcare Conference BOSTON and TEL AVIV, January 8, 2021/PR NEWSWIRE/ – ATP, a leading... |